Semaglutide

Semaglutide, sold under the brand names Ozempic, Wegovy and Rybelsus, is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management, developed by Novo Nordisk in 2012.Semaglutide is a GLP-1 receptor agonist, meaning that it mimics the action of the human incretin glucagon-like peptide-1 (GLP-1), thereby increasing insulin secretion and increasing blood sugar disposal and improving glycemic control.

Read more in the app

Semaglutide Demonstrates Impressive Heart Benefits – Even Before You Lose Weight

Tirzepatide vs. Semaglutide: New Research Reveals Surprising Metabolic Differences

Reversing Liver Disease? Scientists Discover New Health Benefit of Semaglutide

Study reveals distinct mechanisms of action of tirzepatide and semaglutide - EurekAlert!

Semaglutide may provide early protection against heart disease in high-risk patients—even before clinically meaningful weight loss and prior to the full target dose - EurekAlert!

First head-to-head study in people living with obesity shows tirzepatide results in around 50% more weight loss than semaglutide - EurekAlert!

Patients of an online obesity clinic achieved the same weight loss as those in clinical trials of semaglutide – but with much lower doses of the drug - EurekAlert!

Landmark Study Finds Semaglutide Effectively Treats Serious Liver Disease

Semaglutide treats liver disease in two thirds of patients

Semaglutide treats liver disease in two thirds of patients - EurekAlert!

New Pill Form of Semaglutide Shows Major Benefits for People With Diabetes

Will Using Semaglutide Increase Your Risk of Thyroid Cancer?

Lifetime health effects and cost-effectiveness of tirzepatide and semaglutide in US adults - EurekAlert

Beyond Weight Loss: Semaglutide Could Curb Alcohol Cravings According to USC Study

Weight-loss jabs may help reduce alcohol intake, study finds - First clinical trial of its kind has found that semaglutide, distributed under the brand name Wegovy, cut the amount of alcohol people drank by about 40% and dramatically reduced people’s desire to drink.

Heart Shrinkage Linked to Popular Weight-Loss Drug Ozempic/Semaglutide

Insurance coverage, type of employment shape inequities in access to semaglutide - EurekAlert

Semaglutide can have lifetime cost and health - EurekAlert

Protecting Your Kidneys and More: Scientists Identify New Benefits of Semaglutide and Ozempic

Semaglutide may reduce opioid overdoses, a new study suggests